Congratulations to the NIDA labs who participated and received awards in the 2023 NIH Green Labs Program! Molecular Neuropsychiatry Section, Adjei, Nasser – Gold Translational Analytical Core, Kryszak, Lindsay – Silver Neuronal Circuits and Behavior Section, Sarsfield, Sarah – Silver Integrative Neuroscience Research Branch, Neuronal Networks Section, Barbano, Flavia – Bronze Molecular Targets and Medications… [Read More]
Hot Off the Press
Basal forebrain-lateral habenula inputs and control of impulsive behavior.
Hot Off the Press – August 27, 2024 Published in Neuropsychopharmacology by Eun-Kyung Hwang, Agustin Zapata and Carl Lupica, et al. from the NIDA IRP Electrophysiology Research Section. Summary Impulsive behavior is both a predictor and a consequence of drug use and substance use disorders, as well as a symptom of other neuropsychiatric illnesses such… [Read More]
Reviews To Read
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder.
Reviews To Read – August 2024. Published in Current Psychiatry Reports by Kirsten Smith, David Epstein & Stephanie Weiss of the NIDA IRP Translational Addiction Medicine Branch. This publication arose because Dr. Weiss was asked to write about “kratom misuse” for a kratom-focused issue of Current Psychiatry Reports. She agreed to contribute, but with a change… [Read More]
Featured Papers
Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-,-dimethyltryptamine Analogs in Mice
Featured Paper of the Month – September 2025
Published in ACS Chemica Neuroscience by Grant Glatfelter and Michael Baumann of the NIDA IRP Designer Drug Research Unit.
In this study, we show that 5-MeO-DMT and related analogs potently activate 5-HT1A receptors, which tend to decrease the magnitude of 5-HT2A-mediated behavioral effects in mice.
